Biodesix, Inc. (BDSX)
Blood tests that predict lung cancer risk and guide treatment decisions.
$21.03-0.05%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+189.7%
The outlook
Biodesix trades at $21.03, positioned well above both its 50- and 200-day moving averages. All six analysts covering the stock rate it a Strong Buy, with an average price target about 47% above the current level. The stock sits near the upper end of its 52-week range, reflecting sustained upward momentum.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 6 analysts
Price trendAbove its 50- & 200-day averages
52-week range80% of the way from its 52-week low to high
Price targetAvg target +47% vs current price
Analyst price target
~12-month · 6 analysts$30.83average target+46.6% vs now
Now $21.03
Low $26.00High $40.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$217.8M
52-wk high
$24.92
52-wk low
$5.26
50-day avg
$18.21
200-day avg
$12.47
Trailing P/E
—